Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Investigations of the molecular mechanisms underlying major depressive disorder (MDD) have been hampered by the complexity of brain tissue and sensitivity of gene expression profiling approaches. To address these issues, we used discrete microdissections of postmortem dorsolateral prefrontal cortex (DLPFC) (area 9) and an oligonucleotide (60mer) microarray hybridization procedure that increases sensitivity without RNA amplification. Mixed-effects statistical methods were used to rigorously control for medication usage in the subset of medicated depressed subjects. These analyses yielded a rich profile of dysregulated genes. Two of the most highly dysregulated genes of interest were stresscopin, a neuropeptide involved in stress responses, and Forkhead box D3 (FOXD3), a transcription factor. Secondary cell-based analysis demonstrated that stresscopin and FoxD3 are increased in neurons of DLPFC gray matter of MDD subjects. These findings identify abnormal gene expression in a discrete region of MDD subjects and contribute to further elucidation of the molecular alterations of this complex mood disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Missing Value Estimation Methods for DNA Microarrays
Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., Botstein, D., & Altman, R. B. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.6.520 · Cited by 4,230
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Self-citationSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 3×
“Structural brain imaging studies demonstrate atrophy of specific limbic structures, including prefrontal cortex (Drevets et al., 1997; Bremner et al., 2002), hippocampus (Sheline et al., 1996, 1998, 1999; Bremner et al., 2000), and amygdala (Sheline et al., 1998; Hastings et al., 2004).”
BackgroundA molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Self-citationThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 1×
“…studies have demonstrated that expression of CREB can produce antidepressant effects in certain brain regions (Chen et al., 2001a; Wallace et al., 2004), although opposite effects are observed when CREB is expressed in the nucleus accumbens (Pliakas et al., 2001; Nestler and Carlezon, 2006).”
BackgroundHippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 2×
“Structural brain imaging studies demonstrate atrophy of specific limbic structures, including prefrontal cortex (Drevets et al., 1997; Bremner et al., 2002), hippocampus (Sheline et al., 1996, 1998, 1999; Bremner et al., 2000), and amygdala (Sheline et al., 1998; Hastings et al., 2004).”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 2×
“Increased histone H3 dimethylation binding to the BDNF promoter regions 3 and 4 in response to social defeat stress has been reported (Tsankova et al., 2006).”
BackgroundHippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 4×
“…reported a reduction in the density and size of neurons and the number and density of glia in the prefrontal and anterior cingulate cortex, amygdala, and hippocampus, which could contribute to the reduced volume of these regions (Ongur et al., 1998; Rajkowska et al., 1999; Cotter et al., 2001).”
BackgroundInfluentialNemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 5×
“Moreover, previous studies have demonstrated that levels of CRH immunoreactivity are increased in the CSF of depressed subjects (Nemeroff et al., 1984), and postmortem studies report decreased levels of CRH receptor binding in cerebral cortex of suicide subjects (Nemeroff et al., 1988).”
BackgroundInfluentialRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 7×
“…reported a reduction in the density and size of neurons and the number and density of glia in the prefrontal and anterior cingulate cortex, amygdala, and hippocampus, which could contribute to the reduced volume of these regions (Ongur et al., 1998; Rajkowska et al., 1999; Cotter et al., 2001).”
BackgroundMethodResultInfluentialSelf-citationSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1×
“Structural brain imaging studies demonstrate atrophy of specific limbic structures, including prefrontal cortex (Drevets et al., 1997; Bremner et al., 2002), hippocampus (Sheline et al., 1996, 1998, 1999; Bremner et al., 2000), and amygdala (Sheline et al., 1998; Hastings et al., 2004).”
BackgroundThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 1×
“Brain imaging studies demonstrate altered blood flow, metabolism, and morphology in limbic structures of depressed patients (Drevets, 2001; Manji et al., 2001; Nestler et al., 2002a; WarnerSchmidt and Duman, 2006).”
BackgroundDrevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146 · cited 1×
“Brain imaging studies demonstrate altered blood flow, metabolism, and morphology in limbic structures of depressed patients (Drevets, 2001; Manji et al., 2001; Nestler et al., 2002a; WarnerSchmidt and Duman, 2006).”
BackgroundCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 1×
“1998; Cotter et al., 2001, 2002).”
Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · cited 1×
“Compared with controls, depressed patients have elevated cortical glutamate levels (Sanacora et al., 2004) and decreased cortical GABA levels (Sanacora et al., 1999).”
BackgroundRole of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Self-citationPliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · cited 2×
“, 2004), although opposite effects are observed when CREB is expressed in the nucleus accumbens (Pliakas et al., 2001; Nestler and Carlezon, 2006).”
BackgroundAmygdala core nuclei volumes are decreased in recurrent major depression
Sheline, Y. I., Gado, M. H., & Price, J. L. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00021 · Cited by 472 · cited 1×
“Structural brain imaging studies demonstrate atrophy of specific limbic structures, including prefrontal cortex (Drevets et al., 1997; Bremner et al., 2002), hippocampus (Sheline et al., 1996, 1998, 1999; Bremner et al., 2000), and amygdala (Sheline et al., 1998; Hastings et al., 2004).”
BackgroundThe transcriptional control of trunk neural crest induction, survival, and delamination
Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A., & Briscoe, J. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.010 · Cited by 427
Dysregulation of the fibroblast growth factor system in major depression
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406788101 · Cited by 424 · cited 2×
“The results of the current study confirm the findings of a recent postmortem study (Evans et al., 2004), demonstrating decreased expression of FGFR3 in the DLPFC.”
BackgroundResultVolumetric Analysis of the Prefrontal Cortex, Amygdala, and Hippocampus in Major Depression
Hastings, R. S., Parsey, R. V., Oquendo, M. A., Arango, V., & Mann, J. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300371 · Cited by 378 · cited 1×
“Structural brain imaging studies demonstrate atrophy of specific limbic structures, including prefrontal cortex (Drevets et al., 1997; Bremner et al., 2002), hippocampus (Sheline et al., 1996, 1998, 1999; Bremner et al., 2000), and amygdala (Sheline et al., 1998; Hastings et al., 2004).”
BackgroundKos, R., Reedy, M. V., Johnson, R. L., & Erickson, C. A. (2001) · Development · doi:10.1242/dev.128.8.1467 · Cited by 365
Hypercortisolemia and depression
Gillespie, C. F., & Nemeroff, C. B. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163456.22154.d2 · Cited by 361 · cited 1×
“The finding that CRF expression was not altered suggests that the elevated CRF immunoreactivity reported in the CSF of depressed subjects (Nemeroff et al., 1984; Gillespie and Nemeroff, 2005) may not be a result of increased CRF mRNA expression.”
BackgroundExecutive functions and updating of the contents of working memory in unipolar depression
Harvey, P. O., Le Bastard, G., Pochon, J. B., Levy, R., Allilaire, J. F., Dubois, B., & Fossati, P. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.003 · Cited by 359
Cited by
Sex-specific transcriptional signatures in human depression
Labonté, B., Engmann, O., Purushothaman, I., Menard, C., Wang, J., Tan, C., Scarpa, J. R., Moy, G., Loh, Y.-H. E., Cahill, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4386 · Cited by 748
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Kang, H. J., Voleti, B., Hajszan, T., Rajkowska, G., Stockmeier, C. A., Licznerski, P., Lepack, A., Majik, M. S., Jeong, L. S., Banasr, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2886 · Cited by 808
Self-citationAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
“Conversely, repeated treatment with antidepressant medication up-regulates expression of BDNF and FGF2 factors in humans and rodents [183, 191-193].”
BackgroundSelf-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Treatment resistant depression: A multi-scale, systems biology approach
Akil, H., Gordon, J., Hen, R., Javitch, J., Mayberg, H., McEwen, B., Meaney, M. J., & Nestler, E. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.019 · Cited by 442
Metadata
- Authors
- Kang, H. J., Adams, D. H., Simen, A., Simen, B. B., Rajkowska, G., Stockmeier, C. A., Overholser, J. C., Meltzer, H. Y., Jurjus, G. J., Konick, L. C., Newton, S. S., & Duman, R. S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-11-28
- Volume
- 27
- Issue
- 48
- Pages
- 13329-13340
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2145840919
- Cited by
- 119
- References
- 26
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.